TV 7314 (Clopidogrel bisulfate 75 mg (base))

Pill imprint TV 7314 has been identified as Clopidogrel bisulfate 75 mg (base).

Clopidogrel is used in the treatment of ischemic stroke; transient ischemic attack; peripheral arterial disease; heart attack; acute coronary syndrome, prophylaxis (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for TV 7314

Clopidogrel bisulfate 75 mg (base) TV 7314
Clopidogrel bisulfate 75 mg (base) TV 7314
Clopidogrel bisulfate
Imprint:
TV
7314
Strength:
75 mg (base)
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals, USA Inc.
National Drug Code (NDC):
00093-7314
Inactive Ingredients:
crospovidone
hydrogenated cottonseed oil
hydroxypropyl cellulose
hypromellose 2910 (15 mPa.s)
FD&C Blue No. 2
cochineal
aluminum oxide
ferric oxide red
ferric oxide yellow
lactose
lactose monohydrate
microcrystalline cellulose
polyethylene glycol 4000
sodium lauryl sulfate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)